Patent details

EP2804623 Title: CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF

Basic Information

Publication number:
EP2804623
PCT Application Number:
US2013021330
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137356499
PCT Publication Number:
WO2013106787
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF
French Title of Invention:
FACTEUR VIII CHIMÉRIQUE ET POLYPEPTIDES ET LEURS UTILISATIONS
German Title of Invention:
CHIMÄRE FAKTOR-VII POLYPEPTIDE UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
12/01/2013
Grant date:
07/08/2019
EP Publication Date:
26/11/2014
PCT Publication Date:
18/07/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2019
EP B1 Publication Date:
07/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/01/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2019
 
 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, Waltham, MA 02451, United States (US)

Agent

Name:
ARONOVA S.A.
From:
11/11/2019
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
PETERS, Robert
Address:
United States (US)

2

Name:
LIU, Tongyao
Address:
United States (US)

3

Name:
CHHABRA, Ekta, Seth
Address:
United States (US)

4

Name:
JIANG, Haiyan
Address:
United States (US)

Priority

1

Priority Number:
201261586099 P
Priority Date:
12/01/2012
Priority Country:
United States (US)

2

Priority Number:
201261586654 P
Priority Date:
13/01/2012
Priority Country:
United States (US)

3

Priority Number:
201261667901 P
Priority Date:
03/07/2012
Priority Country:
United States (US)

4

Priority Number:
201261734954 P
Priority Date:
07/12/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/37; C07K 14/755; C07K 16/00; A61K 47/62;

Publication

European Patent Bulletin

Issue number:
201932
Publication date:
07/08/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
31/12/2025
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
11/11/2019 Power Of Attorney 1
11/11/2019 Outgoing Correspondence 1